Keppra xr and Spironolactone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Keppra xr (levetiracetam) and Spironolactone (spironolactone). Common drug interactions include muscle spasms among females and arrhythmia among males.

The phase IV clinical study analyzes what interactions people have when they take Keppra xr and Spironolactone. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Keppra xr?

Keppra xr has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 2,272 Keppra xr users. Check the latest studies of Keppra xr.

What is Spironolactone?

Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.



On Jul, 16, 2026

14 people who take Keppra xr and Spironolactone together, and have interactions are studied.

Keppra xr and Spironolactone drug interactions.

What are the common drug interactions of Keppra Xr and Spironolactone, by gender? *:

female:

  1. Muscle spasms (muscle contraction)
  2. Diarrhoea
  3. Headache (pain in head)
  4. Nausea (feeling of having an urge to vomit)
  5. Neuropathy peripheral (surface nerve damage)
  6. Fatigue (feeling of tiredness)
  7. Abdominal pain
  8. Alopecia (absence of hair from areas of the body)
  9. Chest pain
  10. Cough

male:

  1. Arrhythmia (irregular heartbeat)
  2. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  3. Fall
  4. Head injury
  5. Infection
  6. Malignant melanoma (skin cancer rises from melancytes)
  7. Overdose
  8. Post procedural infection
  9. Thyroid cancer

What are the common drug interactions of Keppra Xr and Spironolactone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Muscle spasms (muscle contraction)

40-49:

  1. Confusional state
  2. Contusion (a type of hematoma of tissue in which capillaries)
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Fatigue (feeling of tiredness)
  5. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  6. Head injury
  7. Loss of consciousness
  8. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  9. Swelling
  10. Tremor (trembling or shaking movements in one or more parts of your body)

50-59:

  1. Diarrhoea
  2. Headache (pain in head)
  3. Nausea (feeling of having an urge to vomit)
  4. Neuropathy peripheral (surface nerve damage)
  5. Abdominal pain
  6. Alopecia (absence of hair from areas of the body)
  7. Chest pain
  8. Constipation
  9. Cough
  10. Depressed mood

60+:

  1. Arrhythmia (irregular heartbeat)
  2. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  3. Thyroid cancer
  4. Fall
  5. Head injury
  6. Infection
  7. Malignant melanoma (skin cancer rises from melancytes)
  8. Muscle spasms (muscle contraction)
  9. Overdose
  10. Post procedural infection

What are the existing conditions these people have? *

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 50.00%
  2. Pain: 3 people, 21.43%
  3. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 14.29%
  4. Nail Infection: 2 people, 14.29%
  5. Diarrhea: 2 people, 14.29%
  6. Constipation: 2 people, 14.29%
  7. Headache (pain in head): 2 people, 14.29%
  8. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 2 people, 14.29%
  9. High Blood Pressure: 2 people, 14.29%
  10. Urinary Tract Infection: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Keppra xr and Spironolactone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Keppra xr and Spironolactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Keppra xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Spironolactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keppra xr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Spironolactone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on levetiracetam and spironolactone (the active ingredients of Keppra xr and Spironolactone, respectively), and Keppra xr and Spironolactone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: